openPR Logo
Press release

Digital Therapeutics (DTX) Market Size, Share, and Growth 2035 | 2Morrow, Akili Interactive, Ayogo Health, Better Therapeutics, Big Health, Biofourmis

11-06-2025 10:32 AM CET | Health & Medicine

Press release from: MarketGenics India Pvt. Ltd.

Digital Therapeutics (DTX) Market Size, Share, and Growth 2035 | 2Morrow, Akili Interactive, Ayogo Health, Better Therapeutics, Bi

Digital Therapeutics (DTX) Market Size, Share, and Growth 2035 | 2Morrow, Akili Interactive, Ayogo Health, Better Therapeutics, Bi

A significant study discovering the market avenues on, "Digital Therapeutics (DTX) Market Size, Share & Trends Analysis Report by Therapeutic Application (Diabetes Management, Obesity Management, Cardiovascular Diseases, Central Nervous System (CNS) Disorders, Respiratory Diseases, Substance Abuse Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Sleep Disorders, Chronic Pain Management), Product Type, Sales Channel, Prescription Type, Patient Age Group, Reimbursement Model, Delivery Mode, Technology, End-users, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A holistic view of the market pathways in the Digital Therapeutics (DTX) market underscores revenue acceleration through three key levers scalable product line extensions, high‐maturity strategic partnerships.

Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Digital Therapeutics (DTX) Market Research Report: https://marketgenics.co/reports/digital-therapeutics-market-76048

Global Digital Therapeutics (DTX) Market Forecast 2035:

According to the report, the global digital therapeutics (DTx) market is projected to expand from USD 6.6 billion in 2025 to USD 70.4 billion by 2035, registering a CAGR of 26.7%, the highest during the forecast period. Digital therapeutics (DTx) are medical interventions administered using a clinically proven digital platform and are based on software and delivered to prevent, manage, or treat diseases. These solutions are included in the digital therapeutics market and offer structured therapeutic programs that encourage behavioral change, lifestyle change, and adherence to treatment, which in turn enhance patient outcomes.

In contrast to general wellness or fitness apps, DTx products are evaluated and approved by strict clinical procedures and regulatory standards that are needed to guarantee their safety, efficacy, and reliability. They may be used as an independent prescription or with conventional therapies, which is why they become one of the most important elements of the modern and data-driven healthcare delivery.

The market of digital therapeutics is growing in the fields of diabetes, obesity, cardiovascular diseases, mental illnesses, respiratory diseases, and nervous disorders. With the use of technology, real time follow up, and customized feedback, DTx enables patients to be actively involved in their care and provides healthcare professionals with practical data used to make informed decisions. In sum, the digital therapeutics market is the combination of digital health innovation and clinical medicine, which can provide patient-centered, scalable solutions that can change its accessibility, engagement, and long-term health outcomes.

"Key Driver, Restraint, and Growth Opportunity Shaping the Global Digital Therapeutics (DTX) Market

Digital therapeutics market is growing because of the awareness of preventive healthcare, with more patients and healthcare providers putting emphasis on early interventions to manage and prevent chronic diseases. Digital therapeutics (DTx) solutions provide personalized education, live tracking, and formal lifestyle management support to allow the prevention of the disease proactively. The digital therapeutic market helps to improve the health outcomes, decrease the costs of the long-term treatment and improve the level of patient engagement in self-management and general wellness by promoting early care.

The market of digital therapeutics is constrained by interoperability problems because most DTx platforms have problems with seamless integration with existing healthcare IT systems like electronic health records (EHRs) and hospital management software. Such incompatibility may restrict the exchange of data, interfere with clinical processes, and minimize the performance of digital interventions. Addressing these barriers to integration is essential in improving usability, having coordinated care, and motivating more people to adopt digital solutions in therapeutics.

Pediatric and adolescent healthcare is emerging as a promising segment in the digital therapeutics market, with DTx solutions specifically designed to address chronic disease prevention and management in younger populations. these solutions deliver age-specific advice, interaction features and live tracking to encourage healthy habits at an early age. Digital therapeutics can be used to prevent future disease load, promote long-term well-being, and enable children and adolescents to take an active role in their health by concentrating on prevention and early intervention.

To know more about the Digital Therapeutics (DTX) Market - Download our Sample Report: https://marketgenics.co/download-report-sample/digital-therapeutics-market-76048

Expansion of Global Digital Therapeutics (DTX) Market

"Innovation, pharma demand, and public funding propel the global Digital Therapeutics (DTX) market expansion"

The Digital Therapeutics (DTX) market is undergoing remarkable expansion in the world market, which is mostly caused by the continuous innovations in the field of software, artificial intelligence, and mobile health platforms. In June 2025, Hinge Health launched HingeSelect, a high-performance provider network, which will provide unified musculoskeletal (MSK) care by combining Hinge Health digital exercise therapy (using AI) with a curated network of more than 3,300 vetted in-person providers across all 50 U.S. states. HingeSelect also plans to create a gap between digital and real-life MSK care, providing a smooth experience to the members. The network is made to supplement the current health plan models, offering a complete network that will enhance access to high-value care at a lower cost to employers and health plans.

Government and insurance incentives can greatly drive the uptake of digital therapeutics (DTx) by offering financial assistance and policies. As an example, he Digital Health Incentive Scheme (DHIS) that was launched within the Ayushman Bharat Digital Mission (ABDM) can be viewed as an example of such governmental efforts. According to this scheme, hospitals, diagnostic labs, and digital health solution providers can receive financial incentives up to 4 crores depending on the number of digital health records generated and connected to Ayushman Bharat Health Account (ABHA) numbers.

Regional Analysis of Global Digital Therapeutics (DTX) Market

North America's digital therapeutics (DTX) industry is highly promising due to high healthcare spending, advanced digital infrastructure, and widespread usage of smartphones and wearables. Prescription digital therapeutics are also strongly supported by regulatory agencies such as the FDA, and the reimbursement policies are also favorable, which additionally encourages health care providers and payers. Also, the increase in chronic disease rates, the rise in patient interest in preventive care, and partnerships between technological and pharmaceutical firms are contributing to market expansion in the region. As an example, Pear Therapeutics has created prescription digital therapeutics like reSET and reSET-O substance use disorder that have proven to have quantifiable clinical results and are currently extensively used in the U.S. healthcare system.

The Asian Pacific market for digital therapeutics (DTX) is predicted to grow rapidly due to increased digital infrastructure, smartphone and internet usage, and awareness of preventive management. Government support programs, programs of healthcare digitization and associations between local and international DTX providers are additional support programs that increase market adoption. The emerging markets such as China, India, Japan and South Korea are becoming major markets, exploiting the use of technology-based healthcare solutions in enhancing patient outcomes and decreasing the cost of prolonged treatment. All these factors combined make the Asia Pacific region an extremely promising market of digital therapeutics in the next decade. An example is Practo, a healthcare platform in Bengaluru that has greatly grown its digital health practices in Southeast Asia, Middle East, and Africa.

Prominent players operating in the global digital therapeutics (DTX) market are 2Morrow, Akili Interactive, Ayogo Health, Better Therapeutics, Big Health, Biofourmis, Canary Health, Click Therapeutics, Cognoa, Happify Health, Kaia Health, Livongo Health (Teladoc Health), Mango Health, Mindstrong Health, Noom, Omada Health, Pear Therapeutics, Propeller Health (ResMed), Proteus Digital Health, Voluntis (now part of AstraZeneca), Welldoc, and Other Key Players.

Buy Now: https://marketgenics.co/buy/digital-therapeutics-market-76048

The global digital therapeutics (DTX) market has been segmented as follows:

Global Digital Therapeutics (DTX) Market Analysis, By Therapeutic Application

Diabetes Management

Obesity Management

Cardiovascular Diseases

Central Nervous System (CNS) Disorders

Depression

Anxiety

Schizophrenia

ADHD

Others

Respiratory Diseases

Asthma

COPD

Others

Substance Abuse Disorders

Smoking Cessation

Alcohol Dependence

Opioid Addiction

Others

Gastrointestinal Disorders

Musculoskeletal Disorders

Sleep Disorders

Chronic Pain Management

Global Digital Therapeutics (DTX) Market Analysis, By Product Type

Software Applications

Wearable Devices

Mobile Applications

Web-based Platforms

Virtual Reality (VR) Solutions

Augmented Reality (AR) Solutions

Game-based Therapeutics

Chatbot/AI-powered Solutions

Global Digital Therapeutics (DTX) Market Analysis, By Sales Channel

Business-to-Business (B2B)

Healthcare Providers

Employers

Payers/Insurance Companies

Others

Business-to-Consumer (B2C)

Direct-to-Patient

App Stores

Online Platforms

Others

Global Digital Therapeutics (DTX) Market Analysis, By Prescription Type

Prescription DTx

Non-prescription DTx (OTC)

Global Digital Therapeutics (DTX) Market Analysis, By Reimbursement Model

Pediatric (0-17 years)

Adults (18-64 years)

Geriatric (65+ years)

Global Digital Therapeutics (DTX) Market Analysis, By Patient Age Group

Insurance Reimbursed

Out-of-Pocket

Employer-sponsored

Government-funded Programs

Others

Global Digital Therapeutics (DTX) Market Analysis, By Delivery Mode

Standalone DTx Solutions

Integrated with Medical Devices

Hybrid

Global Digital Therapeutics (DTX) Market Analysis, By Technology

Cognitive Behavioral Therapy (CBT) Digital Programs

Biofeedback Technology

Gamification Technology

Telehealth Integration

Remote Patient Monitoring

Data Analytics & Predictive Modeling

AI & ML Integration

Blockchain Technology

Others

Global Digital Therapeutics (DTX) Market Analysis, by End Use Industry

Healthcare Providers

Hospitals

Clinics

Rehabilitation Centers

Primary Care Physicians

Others

Insurance Companies

Health Insurance Providers

Medicare/Medicaid

Private Insurers

Others

Patients/Individual Consumers

Chronic Disease Patients

Mental Health Patients

Wellness Seekers

Others

Pharmaceutical Companies

Drug Manufacturers

Biotech Firms

Others

Research Institutions

Other End-users

Global Digital Therapeutics (DTX) Market Analysis, By Region

North America

Europe

Asia Pacific

Middle East

Africa

South AmericaAnchor

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

About Us

MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.

We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.

Contact:

Mr. Debashish Roy

MarketGenics India Pvt. Ltd.

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617

Email: sales@marketgenics.co

Website: https://marketgenics.co

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Therapeutics (DTX) Market Size, Share, and Growth 2035 | 2Morrow, Akili Interactive, Ayogo Health, Better Therapeutics, Big Health, Biofourmis here

News-ID: 4256829 • Views:

More Releases from MarketGenics India Pvt. Ltd.

Digital Twins in Healthcare Market Forecast 2035 | Technology Type, Component, Deployment Mode, Application, Technology Integration, Organization Size, Pricing Model, Data Source, Level of Implementation
Digital Twins in Healthcare Market Forecast 2035 | Technology Type, Component, D …
A significant study discovering the market avenues on, "Digital Twins in Healthcare Market Size, Share & Trends Analysis Report by Technology Type (Process Digital Twins, Product Digital Twins, System Digital Twins, Hybrid Digital Twins), Component, Deployment Mode, Application, Technology Integration, Organization Size, Pricing Model, Data Source, Level of Implementation, End-Use Industry, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and
Virtual Tour Software Market to Reach USD 1.1 Billion by 2035 | Rising Demand for Immersive Digital Experiences Drives Growth
Virtual Tour Software Market to Reach USD 1.1 Billion by 2035 | Rising Demand fo …
According to the MarketGenics report, the global virtual tour software market is likely to grow from USD 0.4 Billion in 2025 to USD 1.1 Billion in 2035 at a highest CAGR of 10.5% during the time period. The virtual tour software market is experiencing rapid growth, as organizations are looking to offer more interactive and high-fidelity virtual engagement across a variety of industries like real estate, tourism, education, and enterprise.
Magnetic Sensor Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity
Magnetic Sensor Market Forecast 2035 | Key Driver, Restraint, and Growth Opportu …
Global Magnetic Sensor Market Forecast 2035 According to the report, the global magnetic sensor market is likely to grow from USD 3.2 Billion in 2025 to USD 6.0 Billion in 2035 at a highest CAGR of 5.8% during the time period. The magnetic sensor market is growing fast with an increase in high-precision sensor demand in electric vehicles and industrial automation, sensor technology innovation, including TMR and Hall-effect, and robust growth
Machine Safety Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity
Machine Safety Market Forecast 2035 | Key Driver, Restraint, and Growth Opportun …
A significant study discovering the market avenues on, "Machine Safety Market Size, Share, Growth Opportunity Analysis Report by Safety Type (Functional Safety, Intrinsic Safety, Personal Safety and System Safety), Offering, Safety Function, Connectivity, Machine Type, Application, Industry Vertical and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A complete report exploring emerging market pathways in the machine safety

All 5 Releases


More Releases for Therapeutic

Exosome Therapeutic Market : Detailed Overview
Introduction: The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,
Parkinson's Disease Therapeutic Market Hope for Patients: The Parkinson's Diseas …
Parkinson's Disease Therapeutic Market worth $6.51 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Parkinson's Disease Therapeutic Market - (By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Brand (Branded, Generics), By Route of Administration (Oral, Injectable, Intestinal Infusion, Subcutaneous, Others)),
Global Remote Therapeutic Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Remote Therapeutic Monitoring Market is projected to grow at a CAGR of 17.4% from 2023 to 2028. Medsien, Intellihinc, Zimmer Biomet, Owlytics Healthcare, Limber Health, Medistics, RxCap, Propeller Health, HealthArc, CENSON Health, and B Castle Smith & Co., are some of the key players in the remote therapeutic monitoring market. Browse 147 Market Data Tables and 115
Europe Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Europe Digital Therapeutic (DTx) Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Europe Digital Therapeutic (DTx) market examines the primary segments of the market. This intelligent study provides historical data from forecast.It also provides the details such as whether the customers
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The